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ABSTRACT
FACTORS THAT INFLUENCE PARTICIPATION IN PHYSICAL ACTIVITY IN
ADULTS WITH NONALCOHOLIC FATTY LIVER DISEASE
by
MACY MOSHER
Nonalcoholic fatty liver disease (NAFLD) is a progressive spectrum of disorders
leading to hepatic steatosis is present with no secondary cause of liver disease. NAFLD
is one of the leading cause of chronic liver disease in the United States and the prevalence
of this chronic disease is increasing globally. Despite advances in science and treatment,
providers rely on lifestyle choices and emphasis on physical activity as a main
component of the treatment plan for NAFLD. Physical activity has been well documented
in improving liver function tests and reduces the level of intrahepatic adipose tissue.
Despite the known benefit, persons with NAFLD do not consistently participate in PA.
To date, there are no known studies examining factors that influence level of physical
activity in those with NAFLD. The purpose of this study was to examine fatigue,
depression, perceived illness severity, exercise-self efficacy, and exercise benefits and
barriers as potential factors that may predict level of physical activity in individuals with
NAFLD. A cross-sectional, predictive, correlational study was performed. Ninety-eight
study participants were recruited from a hepatology clinic in Atlanta, Georgia and data
were analyzed to examine predictors of physical activity. Exercise benefits and barriers
were found to be significant predictors of level of physical activity in those with NAFLD.
Additionally, exercise self-efficacy demonstrated a mediator effect on the relationship
between exercise benefits and physical activity. Overall, this research study further
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advances the understanding of symptom burden associated with NAFLD and factors that
may influence level of physical activity.

vii

FACTORS THAT INFLUENCE PARTICIPATION IN PHYSICAL ACTIVITY IN
ADULTS WITH NONALCOHOLIC FATTY LIVER DISEASE

by

MACY MOSHER
A DISSERTATION

Presented in Partial Fulfillment of Requirements for the
Degree of Doctor of Philosophy in Nursing in the Byrdine F. Lewis
College of Nursing and Health Professions
Georgia State University

Atlanta, GA
2021
viii

Copyright by
Macy Mosher
2021
ix

ACKNOWLEDGEMENTS
“I praise you because I am fearfully and wonderfully made; your works are wonderful, I
know that full well.”
Psalm 139:14
This work was made possible by the many mentors, leaders, and clinicians that
have shown me what it is like to be a successful scientist working to improve the lives of
others. I would like to thank Dr. Melissa Faulkner for her steadfast guidance through this
process. I will forever be thankful for your time, experience, knowledge, and dedication.
I am truly grateful for your guidance not only through this extensive dissertation process
but also throughout the doctoral program. I would also like to thank Dr. Mei-Lan Chen
and Dr. Rahul Maheshwari for serving as my dissertation committee members. The
mentorship that you have each provided me is something that I do not take for granted.
Thank you both for spending your time helping to guide me in this experience. I would
like to express my gratitude to Dr. Melissa Osborne for her time and patience in statistical
mentoring. To Natasha and Janelle, thank you for always pointing me in the right
direction. I would also like to thank the patients at the Piedmont Transplant Hepatology
Clinic for their time, sacrifice, and sharing of their unique stories.
To my parents, thank you for instilling in me the true value of persistence,
patience, and commitment for without these I would not know success. Dad, thank you
for teaching me to stay positive, work hard, and make it happen. Mom, I couldn’t have
asked for a better role model. Your strength, faith, and leadership are unmatched. You
are the reason that I chose to become a nurse and your encouragement has pushed me to
the finish line.

x

To my Cody, what else is there to say but we made it! Thank you for helping me
navigate through this journey. I can’t imagine having anyone else by my side. Thank you
for always supporting my crazy dreams, inspiring me to be a better version of myself, and
pushing me to never stop. I would not be where I am today without your love and
support. When I first decided to pursue this doctoral program, little did we know that it
would be during a global pandemic. Thank you for not allowing me to give up and to
just keeping going! This dissertation is dedicated to you and Hattie.
Hattie Jude, may this be an example that the possibilities in life are endless.
There are three goals in life 1) always be kind, 2) strive to push boundaries to leave this
Earth better than when you started, and 3) faith and family above all else. Hattie, thank
you for making me a mama. Mama is a title that I have wanted all of my life. True to
our usual fashion, not only were we faced with navigating a global pandemic, a
dissertation, and a full-time career but we added in a pregnancy and delivery of the most
beautiful gift all at the same time. What a time to be alive! The gift of motherhood has
undoubtedly been the biggest blessing in my life and I strive every day to make you
proud.

xi

TABLE OF CONTENTS
Section

Page

List of Tables ................................................................................................................ xvi
List of Figures.............................................................................................................. xvii
List of Abbreviations .................................................................................................. xviii
Chapter
I.

INTRODUCTION .................................................................................................. 1
Significance of NAFLD ......................................................................................... 1
Background of the Problem .................................................................................... 4
Statement of Purpose .............................................................................................. 5
Study Design and Specific Aims ............................................................................ 6
Theoretical Framework .......................................................................................... 6
Summary............................................................................................................... 10

II.

REVIEW OF THE LITERATURE ...................................................................... 12
Physical Activity .................................................................................................. 12
Fatigue .................................................................................................................. 13
Depression ............................................................................................................ 14
Perceived Illness Severity..................................................................................... 16
Benefits/Barriers ................................................................................................... 17
Self-Efficacy ......................................................................................................... 18
Summary............................................................................................................... 19

xii

Section
III.

Page

STUDY METHODOLOGY ................................................................................. 21
Study Methodology .............................................................................................. 21
Setting .......................................................................................................... 21
Sample ......................................................................................................... 22
Sample Size ................................................................................................. 22
Protection of Human Subjects ..................................................................... 22
Procedures ............................................................................................................ 24
Instruments ........................................................................................................... 24
PROMIS Depression Scale.......................................................................... 24
PROMIS Fatigue Scale................................................................................ 26
Exercise Benefits/Barriers Scale ................................................................. 28
Brief Illness Perception Questionnaire ........................................................ 29
Exercise Self-Efficacy Scale ....................................................................... 30
Concise Physical Activity Questionnaire .................................................... 31
Demographic Intake Form ........................................................................... 32
Data Analysis........................................................................................................ 33
Summary............................................................................................................... 33

IV. STUDY RESULTS .............................................................................................. 35
Study Results ........................................................................................................ 35
Description of Study Sample ................................................................................ 36
Reliability of Study Instruments ........................................................................... 38
Data Analysis Results ........................................................................................... 39

xiii

Section

Page
Descriptive Statistics for Major Study Variables ........................................ 39
Depression ....................................................................................... 40
Fatigue ............................................................................................. 40
Exercise Self-Efficacy ..................................................................... 41
Illness Perception............................................................................. 42
Physical Activity ............................................................................. 42
Research Question One ............................................................................... 43
Research Question Two ............................................................................... 45

Summary............................................................................................................... 47
V.

DISCUSSION AND CONCLUSIONS ................................................................ 49
Fatigue and Depression ........................................................................................ 50
Perceived Illness Severity..................................................................................... 51
Factors Predicting Level of Physical Activity ...................................................... 51
Exercise Self Efficacy as a Potential Mediator of Exercise Benefits to
Physical Activity .................................................................................................. 52
Relationship to Theory ......................................................................................... 53
Limitations of Study ............................................................................................. 54
Strengths of Study ................................................................................................ 55
Implications of Findings on Clinical Practice ...................................................... 56
Recommendations for Future Research................................................................ 56
Study Summary .................................................................................................... 57

REFERENCES .............................................................................................................. 59

xiv

Section

Page

APPENDICES ................................................................................................................ 76
APPENDIX A: Nonalcoholic Fatty Liver Disease and Factors Influencing
Physical Activity Demographic Intake Form ....................................................... 76
APPENDIX B: Fatigue – Short Form 8a ............................................................ 78
APPENDIX C: Emotional Distress – Depression – Short Form 8a .................... 80
APPENDIX D: Exercise Benefits/Barriers Scale................................................ 82
APPENDIX E: Concise Physical Activity Questionnaire CPAQ ....................... 85
APPENDIX F: Brief Illness Perception Questionnaire ....................................... 87
APPENDIX G: Exercise Self-Efficacy Scale...................................................... 90

xv

LIST OF TABLES
Table

Page

1.

Study Participant Demographics .......................................................................... 37

2.

Health Demographics for Study Participants ........................................................ 38

3.

Internal Consistency of Study Instruments............................................................ 39

4.

Descriptive Statistics of Study Variables .............................................................. 40

5.

Correlational Data for All Major Study Variables ................................................ 43

6.

Multicollinearity Diagnostics ................................................................................ 44

7.

Linear Regression Model Summary ...................................................................... 44

8.

Model Coefficients ................................................................................................ 45

9.

Indirect Effect of Self-Efficacy on Exercise Barrier and Physical Activity .......... 46

10.

Indirect Effect of Self-Efficacy on Exercise Benefit and Physical Activity ......... 47

xvi

LIST OF FIGURES
Table

Page

1.

The Modified Health Belief Model (Rosenstock, 1974) for physical activity
in individuals with nonalcoholic fatty liver disease ............................................... 8

2.

Study Participant Screening, Eligibility and Inclusion.......................................... 36

3.

Mediation Model for Exercise Barriers, Exercise Self-Efficacy, and Physical
Activity .................................................................................................................. 46

4.

Mediation Model for Exercise Benefits, Exercise Self-Efficacy, and Physical
Activity .................................................................................................................. 47

xvii

LIST OF ABBREVIATIONS
NAFLD

Nonalcoholic Fatty Liver Disease

PA

Physical Activity

HBM

Health Belief Model

PROMIS

Patient-Reported Outcomes Measurement Information System

EBBS

Exercise Benefits/Barriers Scale

Brief IPQ

Brief Illness Perception Questionnaire

ESES

Exercise Self-Efficacy Scale

CPAQ

Concise Physical Activity Scale

xviii

CHAPTER I
INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) is a growing phenomenon globally and
is associated with other chronic comorbidities. This chronic condition has many negative
disease outcomes including worsening of comorbid metabolic disorders. Treatment
guidelines have evolved to include an emphasis on lifestyle modifications. Individuals
with NAFLD are tasked with modifying nutritional habits, increasing levels of physical
activity, and enhancing weight loss strategies. Despite evidence suggesting that physical
activity can improve both physiologic and psychological outcomes that are commonly
associated with NAFLD (Katsagoni et al., 2016; Chalassani et al., 2012; Mlynarsky et al.,
2016) there remains a gap in knowledge regarding determinants that effect participation
in regular physical activity. This study examined depression, fatigue, benefits/barriers,
perceived illness severity, and self-efficacy as possible factors that may influence
physical activity in persons with NAFLD.
Overview of Nonalcoholic Fatty Liver Disease
Significance of NAFLD
NAFLD is a leading cause of chronic liver disease in the United States and the
prevalence of this chronic disease is increasing world-wide (Younossi et al., 2016).
NAFLD is defined as hepatic steatosis in which there are no secondary causes of liver
disease with no significant alcohol consumption (Chalassani et al., 2012). The threshold
of significant alcohol use is considered to be less than 21 drinks per week for men and
1
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less than 14 drinks per week in women (Sanyal et al., 2011). The occurrence of NAFLD
is increasing with an estimated global prevalence of 25% and an estimate prevalence of
24% in the U.S. (Younossi et al., 2016; Chalassani et al., 2018). Despite the increase in
estimated prevalence of NAFLD, there remains an under-reporting of this chronic disease
on death certificates which leads to an international underestimation of NAFLD (Kim
et al., 2018). Long-term outcomes associated with NAFLD include progressing hepatic
fibrosis (Chalassani et al., 2018) worsening of metabolic syndrome (Younossi et al.,
2016) cardiovascular disease (Azzam & Malnick, 2015) and hepatocellular carcinoma
(HCC) (Chalassani et al., 2018).
Physical Activity and NAFLD
Obesity is estimated to occur in 50% of individuals with NAFLD (Chalassani
et al., 2012; Harrison et al., 2021). Along with obesity and visceral steatosis that are
known metabolic risk factors (Chalassani et al., 2012) NAFLD is associated with
metabolic comorbidities related to obesity such as hypertension, diabetes, insulin
resistance, and hyperlipidemia (Chalassani et al., 2018; Younossi et al., 2012). Lifestyle
modifications such as diet, physical activity, and weight loss are included in the treatment
guidelines for individuals with NAFLD (Chalassani et al., 2018). Physical activity (PA)
is a main component of treatment of NAFLD and is recommended by the American
Association for the Study of Liver Diseases (Chalassani et al., 2018).
A growing amount of evidence suggests that PA improves histologic components
of NAFLD (Chalassani et al., 2012; Katsagoni et al., 2016). Physical activity is
associated with decreased visceral adipose tissue (Katsagoni et al., 2016) and a decrease
in transaminase levels and intrahepatic lipid levels (Chalassani et al., 2012). The U.S.
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Department of Health and Human Services (2018) recommends at least 150 minutes to
300 minutes of moderate-intensity activity per week or 75 to 150 minutes per week of
vigorous-intensity aerobic activity per week in the general population. Several small nonrandomized trials have examined the effect of PA on NAFLD and have focused on a
variety of components of PA including aerobic or resistance training, low, moderate, and
vigorous intensity, diet modification and PA, and duration and frequency of PA
(Katsagoni et al., 2016). Out of the 12 studies included in a meta-analysis on the effects
of exercise on outcomes for individuals with NAFLD (Katsagoni et al., 2016) exercise
alone in individuals with NAFLD improved serum liver lab results and an emphasis on
exercise and diet improved both body mass index and waist circumference. However,
large randomized controlled trials examining the dose effect of PA in NAFLD are lacking
(Chalassani et al., 2018). Currently, there are no universally accepted recommendations
for dose, frequency, or intensity of PA in individuals with NAFLD.
The American Association for the Study of Liver Diseases (AASLD)
acknowledges that moderate-intensity physical activity with weight loss improves hepatic
steatosis, however, they have not made recommendations on the intensity, duration, or
frequency of physical activity (Chalassani et al., 2018). The Korean Association for the
Study of the Liver (KASL) guidelines recommend exercising for at least thirty minutes
twice per week to reduce the lipid-associated inflammation of the liver (KASL, 2013).
The European Association for the Study of the Liver (EASL) recommends moderateintensity aerobic physical activity to total 150-200 minutes per week in addition to
resistance training (EASL, 2015). Ultimately, PA recommendations should be
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individually tailored based on health status, preference, and clinical characteristics
(EASL, 2015).
Background of the Problem
Despite the evidence to support the benefit of PA on outcomes related to NAFLD,
individuals with NAFLD do not consistently participate in PA. Fifty-four percent of
individuals with NAFLD reported an activity level of inactive and 57% of those who
reported being inactive did not spending any time in recreational activities (Kistler et al.,
2011). Additionally, in a self-reported analysis, only 20% of individuals with mild and
moderate steatosis related to NAFLD reported meeting the Surgeon General’s report
guidelines for PA (Krasnoff et al., 2008). It is estimated that about one-half of U.S.
adults in the general population are meeting recommendations for physical activity to
prevent chronic disease (CDC, 2019). The benefits of PA include lowering blood
pressure, reducing risk of stroke and cardiovascular disease, improving mental health,
and preventing weight gain (CDC, 2019).
Increasing PA in individuals with NAFLD can be beneficial. However, there
remains a gap in the evidence of factors influencing the decision to participate in PA in
this chronic disease population. Barriers and benefits for regular PA in individuals with
NAFLD should be considered to enhance participation in PA and improve outcomes.
Determining perceived benefits and barriers to PA should be used in developing
interventions that will be most effective to improve PA levels in individuals with
NAFLD.
Previously documented barriers to PA in other populations of chronic illness
include lack of motivation (Veldjuijzen van Zanten et al., 2015) fatigue (Blake et al.,
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2015; Egerton et al., 2016; Veldjuijzen van Zanten et al., 2015) and depression
(Roshanaei-Moghaddam et al., 2009). Individuals with NAFLD are at a higher risk of
significant depression (Bianchi et al., 2005) and fatigue (Assimakopoulos et al., 2018)
which may impact the decision to participate in PA. Perceived benefits of PA in
individuals with a chronic illness include improvement in mood, decrease in fatigue,
overall improvement in body functioning, and improvement in overall health (Rehm &
Konkle-Parker, 2016).
In addition to psychosocial factors and benefits/barriers, exercise self-efficacy and
perceived illness severity may impact the decision to participate in PA in individuals with
NAFLD. Enhancing self-efficacy has demonstrated a positive association with impacting
the decision to participate in PA (Klompstra et al., 2018; Veldjuijzen van Zanten et al.,
2016). The individual’s perception of the severity of illness may also impact levels of PA.
In a study of individuals with chronic lung disease, a higher perceived severity of illness
correlated with a reduced level of PA (Zoeckler et al., 2014). Psychosocial variables,
benefit/barriers, exercise self-efficacy, and perceived severity of illness were examined in
the current study to determine their effect on levels of PA participation.
Statement of Purpose
Although evidence suggests that PA improves the physiologic impact of NAFLD
and is now considered part of the treatment guidelines, no studies were found that
discussed factors associated with PA in individuals with NAFLD. Through exploring
similar factors that have been associated with participating in PA in other population of
chronic illness that include fatigue (Egerton et al., 2016) depression (Roshanei-
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Moghaddam et al., 2009) self-efficacy (Veldjiuijzen van Zanten et al., 2016) and
perceived severity of illness (Zoeckler et al., 2014).
The purpose of this study is to gain an understanding of their impact, as well as
benefits and barriers on PA participation in individuals with NAFLD. The potential
mediating effect of self-efficacy on the relationships between benefits or barriers and PA
was also be examined. Information obtained in this research will inform the development
of targeted innovative interventional strategies to improve PA in this population.
Study Design and Specific Aims
A cross-sectional, correlational study design was used to gain a more
comprehensive understanding of key factors that influence current participation in PA by
individuals with NAFLD. The possible effect of exercise self-efficacy on perceptions of
benefits or barriers to current level of physical activity was also examined. Accordingly,
the following research questions were investigated in individuals with NAFLD.
1) Do symptoms of fatigue or depression, perceptions of level of illness severity or
benefits and barriers to physical activity predict the amount of self-reported
physical activity?
2) Does exercise self-efficacy mediate the relationship between perceptions of
benefits or barriers for physical activity and self-report physical activity?
Theoretical Framework
This study was guided by the Health Belief Model (HBM), a well-established
theory that grew out of a group of independent concepts of public health interest in the
U.S. between the 1950’s and 1960’s (Rosenstock, 1974). The HBM is an expectancy
theory which postulates that an individual will decide to act based on the perceived threat
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of disease, the evaluated benefit of the proposed health action, and an internal or external
stimulus that triggers the individual to participate in the appropriate health behavior
(Maiman & Becker, 1974). The HBM is one of the most widely used theoretical
frameworks in understanding health behaviors (Painter et al., 2008). The five major
theoretical concepts of the HBM include: 1) perceived severity, 2) perceived
susceptibility, 3) perceived benefits/barriers, 4) cues to action, and 5) self-efficacy.
The HBM examines an individual’s assessment to engage in a health behavior and
is based on the perspective of the individual (Maiman & Becker, 1974). The HBM
theorizes that in order for an individual to decide to participate in the health behavior,
they must feel as though they are vulnerable to the health condition that would impact
their individual quality of life (Rosenstock, 1974). The HBM can be summarized into
three main components which include 1) perceived severity or threat of the health
condition, 2) modifiable risk factors such as psychosocial, structural, and triggers, and 3)
the commitment to engage in the health behavior of interest.

8

Figure 1: The modified Health Belief Model (Rosenstock, 1974) for physical activity in
individuals with nonalcoholic fatty liver disease.
Psychosocial
Variables:
• Depression
• Fatigue

Self-Efficacy
Structural Variables:
• Perceived
benefit
• Perceived
barriers

Physical activity

Individual
Perception:
Perceived
Severity of
NAFLD

Perceived Threat
Perceived threat is a major theoretical concept of the HBM that can be described
as the individual’s perception of the threat, susceptibly, and severity of the disease
(Rosenstock, 1974). The perceived threat is subjective and varies based on the
individual’s perception of the risk of disease (Rosenstock, 1974). In individuals with
NAFLD, their perceived threat of this disease process may vary based on
symptomatology, severity of disease, other comorbidities, and knowledge of the disease
process. NAFLD without significant liver failure is reported to not have an association
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with perceived illness (Mlynarsky et al., 2016). This may indicate that an individual does
not have a significant perceived threat of NAFLD and thus may choose not to participate
in PA. This study assessed perceived severity of NAFLD with the HBM theoretical
framework to determine its relationship to level of PA.
Modifiable Risk Factors
The HBM framework includes sociopsychological and structural variables and
aims to examine the relationship between these variables and the decision to engage in
the proposed health behavior. The current study examined depression and fatigue as two
sociopsychological variables that may impact the decision to participate in PA. These
variables were included due to the documented increase in risk for depression and fatigue
in individuals with NAFLD (Assimakopoulos et al., 2018; Bianchi et al., 2005).
Additionally, fatigue and depression are both considered modifiable and have previously
demonstrated a correlation with reduced activity levels in other populations (Egerton
et al., 2016; Roshanaei-Moghaddam et al., 2009).
Self-efficacy is theorized as an individual’s belief that they are able to implement
the proposed health behavior (Bandura, 1977). Self-efficacy was examined in this
proposed study as a mediator variable that may impact the relationship between perceived
benefit/barriers of PA and participation in PA. An increased perceived self-efficacy has
been correlated with an increased level of PA (Mo et al., 2011). Lastly, perceived benefits
and barriers to participation in PA were measured to determine the effect of these
variables on participation in PA, the targeted health behavior and study outcome.
Physical activity is a priority outcome due to the positive effects on metabolic processes
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associated with NAFLD and the current evidence that individuals with NAFLD are not
physically active.
Application of the HBM to NAFLD
The HBM was originally developed to understand behaviors in regards to
prevention of chronic illness (Champion, 1984) however, the application of HBM to
understand secondary health prevention behaviors has evolved to include studies about
PA (Mo et al., 2016), infectious disease practices (Padchasuwan et al., 2016), nutrition
behavior (Jeong & Ham, 2018; Kim et al., 2012) dental hygiene (Lee et al., 2018),
medication adherence (Obirikorang et al., 2018) and substance use (Mona et al., 2014).
Additionally, the HBM has been studied in many populations of chronic illness including
congestive heart failure (Baghianimoghadam et al., 2013) osteoarthritis (Ang et al., 2008)
hypertension (Obirikorang et al., 2018) and diabetes mellitus (Koch, 2002). The HBM
has been applied and critiqued in a variety of populations and health behaviors and has
been well documented in research focusing on PA. The application of the HBM aided in
explaining factors that affected a significant increase in PA (Hoseini et al., 2014). Based
upon the strong evidence of the applicability of the HBM to health behaviors in persons
with chronic illnesses, the model is well justified to guide the examination of the possible
relationships of the variables of interest in this proposed investigation (see Figure 1).
Summary
This study examined the modifiable factors of perception of fatigue, depression,
illness severity and benefits or barriers for engaging in physical activity, as well as the
mediating effect of self-efficacy between benefits or barriers and PA. A better
understanding of the determinants of PA in NAFLD will help to yield new discoveries in
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enhancing this lifestyle modification, impact therapeutic strategies, and improve overall
health status of this chronic disease population. This proposal provides valuable resources
for the larger scientific community to pursue additional studies on PA and liver disease.

CHAPTER II
REVIEW OF THE LITERATURE
The goal of this study was to examine the factors that influence participation in
physical activity (PA) in individuals with non-alcoholic fatty liver disease (NAFLD).
This chapter contains a review of the literature related to the Health Belief Model as a
theoretical framework selected to guide this study examining fatigue, depression,
benefits/barriers, perceived severity, and self-efficacy and the impact of these factors on
self-reported level of PA. The Cumulative Index to Nursing & Allied Health Literature
(CINAHL), PubMed, Medline, and ProQuest databases were used to conduct this review.
Numerous search terms were used in this review including: NAFLD, physical, fatigue,
depression, benefits, barriers, perceived severity, Health Belief Model, and self-efficacy.
Physical Activity
Current treatment guidelines for the management of NAFLD include
recommendations for diet modifications, PA, and weight loss (Chalassani et al., 2018).
Physical activity is a major component of management and prevention of NAFLD.
Physical activity has demonstrated an improvement in the histological components of
NAFLD, however, there are no universal recommendations for dose, frequency, or
intensity of PA in individuals with NAFLD. Despite the guidelines emphasizing the
importance of PA in treatment of NAFLD, only 20% of individuals with NAFLD
reported being active (Krasnoff et al., 2018). When compared with a healthy control
group, individuals with NAFLD spent an extra thirty minutes per day being sedentary and
12
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walked 18% fewer steps per day (Hallsworth et al., 2015). This study aimed to examine
constructs established in the theoretical foundation of the health belief model that impact
participation in PA in individuals with NAFLD.
Factors Associated with Physical Activity
Fatigue
The concept of fatigue is dynamic and complex and there is not a standardized
definition (Engberg et al., 2017). Lower levels of fatigue have been traditionally reported
in individuals who self-reported better overall health (Egerton et al., 2017). Despite the
wide array of methods used to assess fatigue, there is no universally accepted
methodology (Engberg et al., 2017). The estimated prevalence of fatigue in the U.S.
workforce is 37.9% and is found to be significantly higher in individuals who reported
two or more health conditions (Ricci et al., 2007). In populations of chronic illness,
fatigue is a commonly reported symptom. For example, 68% of individuals with diabetes
mellitus reported having fatigue (Jain et al., 2015). Fatigue was reported in 52.5% of
individuals with thyroid cancer and was inversely correlated with level of PA (r=.265,
p<.001) (Alhashemi et al., 2017). Additionally, feelings of fatigue were reported in 67%
of surveyed adults with chronic congestive heart failure in addition to impairments in
level of activity (Kraai et al., 2016). Fatigue is a common barrier to PA and was reported
by 13% of individuals with colorectal cancer (Fisher et al., 2016).
Fatigue was correlated with lower levels of PA in an international group of adults
and those with significant fatigue were associated with 1,150 less steps per day, a 17%
reduction, than those who did not report fatigue (Egerton et al., 2016). Fatigue was also
higher in women (Egerton et al., 2017)25 advanced age, and was more common in those
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that were obese (Egerton et al., 2016). Participation in leisure activity demonstrated a
significant association with lower levels of fatigue, and longer times of sitting correlated
with higher overall fatigue scores (Egerton et al., 2017).
Similar to findings with persons experiencing other chronic illnesses, fatigue is a
commonly reported symptom associated with chronic liver disease across etiologies
including NAFLD (Assimakopoulos et al., 2018; Dwight et al., 2000). Individuals with
NAFLD experience a significantly higher level of fatigue when compared with those
without liver disease (Newton et al., 2008) and this is reported to be a main reason for not
participating in PA in 12.9% of persons with NAFLD (Mlynarsky et al., 2016).
The unique physiologic pathway of fatigue in individuals with NAFLD is not
fully understood. It is hypothesized that the role of the liver in regulating the storage and
release of energy and the inflammatory mechanisms associated with NAFLD are directly
related to fatigue in this population (Gerber et al., 2019). Individuals with NAFLD that
had higher levels of fatigue demonstrated lower levels of activity and more prominent
somatic symptomatology (Assimakopoulos et al., 2018; Newton et al., 2008). Fatigue
was inversely correlated with steps per day in individuals with NAFLD compared to
those without NAFLD, and those with NAFLD also took significantly fewer steps per
day (Newton et al., 2008). Fatigue did not demonstrate a relationship with severity of
histological markers of NAFLD (Newton et al., 2008) or severity of liver disease (Dwight
et al., 2000). Physical activity with weight loss demonstrated an improvement in fatigue
scores amongst individuals with NAFLD (Tapper & Lai, 2015).
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Depression
Fatigue and depression frequently co-exist in individuals with chronic liver
disease (Dwight et al., 2000). Individuals with chronic illness, such as liver disease, are at
a higher risk of significant depression and the severity of their depression commonly
impacts their level of PA. In persons with depression, every one-point increase as
measured by depression in the Montgomery-Asberg Depression Rating Scale (MADRS)
(Montgomery & Asberg, 1979) is reported to have a 2.4-minute reduction in average
activity measured via accelerometer (Helgadottir et al., 2015). Higher levels of
depression are found to be negatively associated with time spent in physical activity in
persons with other chronic disease, such as heart failure (Haedtke et al., 2017) and cancer
(Liu et al., 2017).
In other research examining depression and PA, persons with chronic pulmonary
disease that reported meeting PA guidelines were less likely to have major depression
than those who did not meet PA guidelines (OR =.41, 95%, CI: 0.18-0.94) (Loprinzi
et al., 2013). Interestingly, PA was inversely related to depression in a dose-response
manner (Loprinzi et al., 2013). This may suggest that the amount or dose of PA may
serve as an intervention to improve overall depression. The positive effect of PA as an
intervention for depression was also evident in populations with chronic illness including
arthritis (Kelley et al., 2015), systemic lupus erythematosus (O’Dwyer et al., 2017) and
myeloproliferative neoplasms (Eckert et al., 2017). However, there is a paucity of
research that examines the effect of depression severity on the level of PA in individuals
with NAFLD.
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Of particular concern is the prevalence of depression in persons with chronic liver
disease that are 2.2 times more likely to have major depression when compared with the
general population (Bianchi et al., 2005). Depression has been independently associated
with a diagnosis of NAFLD (Elwing et al., 2006). In a sample of 156 participants with
mixed liver disease etiology, 56.7% of the participants had scores that indicated clinical
depression (Youssef et al., 2013). In a review of a large clinical database of individuals
with NAFLD, 67% of individuals had either clinical or subclinical depression (Weinstein
et al., 2011).
Individuals with NAFLD are at a higher risk of depression than those with
Hepatitis B (Elwing et al., 2006). Adults with NAFLD and comorbid depression are more
likely to have more severe steatosis (Nardelli et al., 2016; Youssef et al., 2013).
Individuals with NAFLD and depression are less likely to respond to cardiometabolic risk
factor reductions strategies and can be resistant to standard treatment (Nardelli et al.,
2016). These issues persist because little is known about the etiology of depression in
persons with NAFLD and there are no current recommendations for depression
screenings in this population (Chalasani et al., 2018). Along with depression, research
indicates NAFLD is associated with an overall decrease in quality of life (Fabregas et al.,
2013; Gallegos-Orzoco et al., 2003; Santos et al., 2012). The current state of the
evidence suggests that NAFLD is directly associated with an increased risk of depression.
Perceived Illness Severity
Perceived illness severity has a significant impact on adaptation to chronic illness
and should be considered in research focusing on improvement of chronic health status
(Groarke et al., 2004). Previous empiric evidence has demonstrated an inverse
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relationship between perceived severity of illness and level of PA (Zoeckler et al., 2014).
For example, in individuals with rheumatoid arthritis, a higher perceived disease severity
was found in those with high levels of depression and pain and a lower perceived disease
severity was associated with good physical function, lower levels of pain, and lower
depression scores (Groarke et al., 2004).
In a cross-sectional study, 57.2% of individuals with NAFLD reported not fully
understanding NAFLD, 53.6% identified NAFLD as a chronic condition, and 60%
believed that NAFLD is considered a major health concern (Zelber-Sagi et al., 2017).
Additionally, only 53.4% of individuals with NAFLD reported anticipating a medical
complication related to NAFLD (Zelber-Sagi et al., 2017). The perceived cause of
NAFLD varied, however, 6.3% of study participants reported the cause of NAFLD to be
lack of PA (Zelber-Sagi et al., 2017). These data suggest inconsistent perceptions of the
seriousness of NAFLD and that those with NAFLD may not perceive a high severity of
this chronic disease.
Benefits/Barriers
An individual’s perception of benefits and barriers to participation in PA may
influence their participation in consistent activity. Thus, examining the relationship
between benefits/barriers and level of PA and specific benefits/barriers reported by
populations of interest may be beneficial in improving activity level. Improving fitness,
improving overall health, and maintaining or losing weight are commonly reported
benefits of PA (Fisher et al., 2016). Almost all participants with multiple myeloma
responded that PA improves overall health and also aided in enjoyment of life and social
interaction (Craike et al., 2013). Participation in a PA intervention improved anxiety,
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fatigue, motivation, and general body aches in adults with acute leukemia (Bryant et al.,
2017). Individuals with multiple sclerosis reported that the improvement in physical
performance and feelings of personal accomplishment were the greatest perceived benefit
of PA and that physical exertion and lack of access to exercise facilities were the greatest
barriers to (Stroud et al., 2009). Liu et al. (2017) found that the degree of perceived
benefit of PA was correlated with improvement in level of PA.
Age, general musculoskeletal aches, difficulty breathing, and lack of time are
commonly reported barriers to PA (Fisher et al., 2016). Additional barriers to PA in
individuals with multiple myeloma included fatigue, pain, low interest in PA, low selfefficacy, and concern about symptoms of chronic illness and side effect of treatment
(Craike et al., 2013). Physical symptom burden is also a commonly reported barrier to PA
(Bryant et al., 2017). Individuals who reported any barrier to PA were significantly less
likely to participate in PA then those who did not report any barriers (Fisher et al., 2016).
In individuals with NAFLD, 32.9% reported avoiding PA (Mlynarsky et al.,
2016). Total time spent participating in PA was twice as high in individuals without
NAFLD when compared to those with NAFLD (Mlynarsky et al., 2016). The most
common barriers reported in individuals with NAFLD in participating in PA were
boredom, no available time, and fatigue (Mlynarsky et al., 2016).
Self-Efficacy
Perceived self-efficacy is a major determinant in participation in behavioral
activities, how much effort will be spent in achieving the activity, and how long the effort
will be sustained (Bandura, 1977). Individuals tend to avoid situations where they feel
incapable of managing their coping skills in threatening situations, however, they decide
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to participate in an activity they feel they are capable of managing (Bandura, 1977). Selfefficacy has consistently demonstrated a positive association with level of activity in a
variety of populations (Blake et al., 2016; Kasser & Komo, 2012; Zelber-Sagi et al.,
2017). Self-efficacy has demonstrated a strong correlation with PA (r=.40, p<.01) and is a
predictor of the level of PA (Blake et al., 2016; Kasser & Kosmo, 2012). Individuals with
higher perceived self-efficacy experienced fewer barriers to exercise (Kasser & Kosmo,
2012). This may indicate that enhanced self-efficacy can help individuals overcome
barriers to exercise, thus, having higher levels of PA.
Limited research has focused on self-efficacy in persons with NAFLD. In a study
by Zelber-Sagi and colleagues (2017) they found that a moderate to high level of selfefficacy was associated with healthy eating habits and a positive perception of treatment
effectiveness. However, self-efficacy specific to physical activity was not measured. A
high perception of self-efficacy may positively influence the commitment to participation
in PA. Thus, a high perceived self-efficacy may impact the relationship between
perceived benefits and overall level of PA. Alternatively, a low perceived self-efficacy
may influence the relationship between perceived barriers and PA.
Summary
This chapter provided an examination of the current state of the literature in
regards to evidence supporting the use of PA in treatment of NAFLD. Additionally, the
Health Belief Model was the guiding theoretical framework for this study due to its
relevance to the variables of interest, compatibility with current state of the literature, and
its extensive use in studying factors that may influence participation in PA. Depression,
exercise benefits and barriers, perceived illness severity, and fatigue have all been studied
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in other chronic health conditions as potential factors influencing PA. Additionally,
individuals with NAFLD are at increased risk of these disease symptoms. Through
evaluating PA level guided by the constructs of the Health Belief Model researchers may
be better able to tailor future interventions to improve health outcomes.

CHAPTER III
STUDY METHODOLOGY
A cross-sectional, correlational study design was used to examine the
relationships among fatigue, depression, illness perception or benefits or barriers on the
level physical activity (PA) in individuals with nonalcoholic fatty liver disease (NAFLD).
Additionally, exercise self-efficacy was examined as a potential mediator of the effect of
exercise benefits or barriers on the level of PA in this population. This chapter includes
the procedural aspects of this study including subject recruitment, enrollment, consent
procedures, process for data collection, data management, as well as data analysis. The
specific research questions for the study are:
1) Do symptoms of fatigue or depression, perceptions of level of illness severity
or benefits and barriers to physical activity predict the amount of self-reported
physical activity?
2) Does exercise self-efficacy mediate the relationship between perceptions of
benefits or barriers for physical activity and self-reported physical activity?
Setting
The setting for the study recruitment occurred at the Piedmont Transplant
Hepatology Clinic in Atlanta, Georgia. This hepatology clinic services patients from all
over the Southeastern region of the United States that include the states of Georgia,
Alabama, and South Carolina. The clinic serves patients with a variety of hepatology
related concerns including an estimated 30 individuals per week with NAFLD.
21
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Sample
This study included both female and male participants with NAFLD with equal
numbers to minimize variability of findings based upon sex. Inclusion criteria includes
individuals (a) between the ages of 18-75, (b) diagnosed with NAFLD documented by a
clinical diagnosis and recorded on the medical record, and (c) are able to speak, read and
write in English. Exclusion criteria includes (a) other significant medical diagnoses, (b)
etiology of liver disease other than NAFLD, (c) any previously diagnosed mental health
disorder, (d) currently taking prescribed medication for depression (or within previous
three months), (e) active alcohol or substance use (f) mobility limitations (current use of
walker, cane, or wheelchair), and (g) any person that has been seen in the clinic for less
than three months.
Sample Size
A power analysis was conducted apriori utilizing G*Power (Faul et al., 2009) for
multiple regression with six predictors, F-squared effect size of .15, alpha of .05, and a
power of .80 to determine recommended total sample size. The sample sized is estimated
at 98. Over-recruitment of study participants was considered to control for possible
incomplete data sets. The estimated total sample size included 105 participants.
Protection of Human Subjects
Prior to data collection, this study proposal was approved by the Georgia State
University Institutional Review Board and the Piedmont Healthcare Institutional Review
Board. Potential study participants were informed of the aims of the study and were
voluntarily enrolled. Written informed consent and HIPAA authorization forms were
obtained from each study participant by the investigator prior to participant enrollment.
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All participants were notified of their right to withdraw from the study at any point
without penalty. Information regarding the study was provided to each study participant
by the investigator. Information regarding the right to confidentiality was provided to
each study participant. An introductory meeting with each participant was held with the
primary investigator to complete informed consent, voluntary enrollment and to receive
information on the right to withdraw and study instructions. Potential study participants
were assured that their decision to participation in the research study would have no
impact on their medical care. There were no financial costs to study participants other
than the use of their time to complete study instruments.
Due to the design of this research, there were minimal expected risks to study
participants. The burden of completing study instruments could have led to research
fatigue and was assessed on an ongoing basis. Additionally, if scores on the PROMIS
depression scale were indicative of moderate or severe depression, study participants
were referred for additional treatment. Collaboration with the Piedmont Healthcare
psychiatric mental health nurse practitioner was conducted prior to data collection. This
collaboration served as a point of referral as needed for individuals that scored greater
than 60 on the PROMIS depression 8a scale. Data were monitored every 48 hours by the
primary investigator to identify participants that scored above the cutoff score. These
individuals were referred to the Piedmont psychiatric nurse practitioner for additional
screening and treatment as needed. This referral to the psychiatric mental health nurse
practitioner was made by the primary investigator on an as needed based on PROMIS
depression data.
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Procedures
Hepatology providers at Piedmont Hepatology Clinic were made aware of the
proposed research topic, eligible study participants, ineligibility criteria, and were
provided contact information for the lead nurse researcher. The primary investigator
made weekly visits to the hepatology clinic to engage with the staff at the clinic to answer
research-related questions and to screen for potential study participants.
Data collection occurred at a standard outpatient hepatology clinic appointment.
Data were collected utilizing printed self-reported study instruments. Participants were
provided a private space to complete the study instruments. It is estimated that it took
each study participant around 25-30 minutes to complete all study instrument items. Prior
to the self-administration of the instruments, the study participants met briefly with the
primary investigator to provide instruction on data collection and to answer any researchrelated questions. Study participants were asked to self-administer the instruments
without family or social support input. Data collected from the study instruments were
de-identified using study ID numbers for each participant and entered directly into SPSS
statistical software.
Instruments
PROMIS Depression Scale
The Patient-Reported Outcomes Measurement Information System (PROMIS)
depression short form 8a was used to measure depression in this proposed study. This
instrument assesses depression through self-reported feelings of sadness, guilt, selfcriticism, worthlessness, loneliness, interpersonal alienation, and loss of interest
(PROMIS Health Organization, 2019a). This depression scale was developed for
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universal implementation and is not disease-specific (PROMIS Health Organization,
2019a). This PROMIS tool is intended for adults over the age of 18 and assesses
depression over the past 7-day period (PROMIS Health Organization, 2019a). The short
form was chosen due to the brevity of administration and participants were instructed to
answer all of the instrument items. The most recent version, 8a, was chosen due to the
recommendation by the instrument developers to use the highest or more recent version
number.
The PROMIS depression short form 8a is an 8-item questionnaire with a fivepoint Likert response option ranging from “never” to “always” (PROMIS Health
Organization, 2019a). The raw score on this depression scale ranges from 8-40, with a
higher score indicating more significant clinical depression (PROMIS Health
Organization, 2019a). Raw scores can be applied to the score conversion table to
establish a T-score
(https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Depression_Scorin
g_Manual.pdf). A final score is represented by a T-score which indicates the overall
standardized score. The T-scores range from 38.2-81.3 and the mean T-score is 50 with a
standard deviation of 10 (PROMIS Health Organization, 2019a). A T-score less than 55
is considered normal, 55-60 mild depression, 60-70 moderate depression, and greater
than 70 is indicative of severe depression (PROMIS Health Organization, 2019a). The
mean or calibrated scores were developed for this depression scale through screening of a
general population. The PROMIS depression short from 8a scale has been used
previously for data collection via paper or online tools (PROMIS Health Organization,
2019a).
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This PROMIS instrument assesses self-reported perception of depression and has
been widely used and accepted in both the general population and populations with
chronic illness (Flynn et al., 2015). The Cronbach’s alpha for the depression short form in
a population of persons with heart failure awaiting transplant was 0.91 and construct
validity was established by comparing correlations between this PROMIS form and other
measures of depression (PHQ-2) (Flynn et al., 2015). Additionally, a significant
correlation was found between administration of the computer-adapted version and the
short form highlighting the validity of the short form (Flynn et al., 2015). While no
studies were found that discuss the reliability of PROMIS measures in persons with
NAFLD, PROMIS depression measures were studied in individuals with liver cirrhosis
(Bajaj et al., 2011). Lastly, test-retest reliability in persons with cirrhosis identified an
interclass correlation range from 0.759-0.985 when the PROMIS depression measure was
administered 12 days apart (Bajaj et al., 2011).
PROMIS Fatigue Scale
The concept of fatigue was measured using the Patient Reported Outcome
Measurement Information System (PROMIS) fatigue short form 8a. The PROMIS
fatigue scale assesses fatigue through self-reported symptoms including tiredness, sense
of exhaustion, frequency, duration, and intensity of fatigue, and the impact of fatigue on
daily activities (PROMIS Health Organization, 2019b). The PROMIS fatigue short form
8a is designed for adults over the age of 18, has been universally developed, and is not
disease specific (PROMIS Health Organization, 2019b).
The PROMIS fatigue scale is an 8-item self-reported instrument with a five-point
Likert response ranging from “not at all” to “very much” (PROMIS Health Organization,
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2019b). The raw scores on the PROMIS fatigue short form 8a range from 8-40 (PROMIS
Health Organization, 2019b). The raw scores are converted into T-scores based on a
conversation table
(https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Fatigue_Scoring_
Manual.pdf). The T-scores of this scale range from 33.1-77.8 with a mean T-score of 50
and standard deviation of 10 (PROMIS Health Organization, 2019b). This instrument
assess fatigue over the past 7 days and higher T-score is representative of more severe
fatigue (PROMIS Health Organization, 2019b). A T-score of 55-60 is considered mild
fatigue, 60-70 moderate fatigue, and greater than 70 is indicative of severe fatigue
(PROMIS Health Organization, 2019b).
The PROMIS fatigue short form 8a has demonstrated appropriate reliability and
validity in a variety of patient populations including those with chronic illness
(Ameringer et al., 2016). A secondary data analysis reviewed the psychometric data of
the PROMIS fatigue short form 8a in five sample populations of persons with
fibromyalgia, sickle cell disease, cardiometabolic risk, pregnancy, and healthy controls
(Ameringer et al., 2016). The Cronbach’s alpha reliability coefficient in these persons
with chronic illness ranged from .72 to .86 (Ameringer et al., 2016). Additionally,
concurrent validity was measured between the PROMIS fatigue scale and the Brief
Fatigue Inventory (BFI) and correlations ranged from r=.60 to .85. While no studies were
found that examined the use of the PROMIS fatigue scale in persons with NAFLD, the
PROMIS fatigue scale demonstrated acceptable reliability, Cronbach alpha > .87 in a
cohort study of individuals with liver cirrhosis (Evon et al., 2017).

28

Exercise Benefits/Barriers Scale
Individual perceptions of benefits and barriers to PA were measured using the
Exercise Benefits/Barriers Scale (Sechrist et al., 1987). The Exercise Benefits/Barriers
Scale (EBBS) is a 43-item instrument with a four-point Likert scale option ranging from
“strongly agree” to “strongly disagree” (Sechrist et al., 1987). While the EBBS is one
instrument, it is subdivided into two subscales including a benefits and a barriers scale
(Sechrist et al., 1987). Scores are summed for each subscale to create a total score. The
total score for the benefits scale ranges from 29 to 116 and the total score for the barriers
scale is 14 to 56 (Sechrist et al., 1987). A higher total score indicates an overall positive
perception of the benefits of PA (Sechrist et al., 1987). All items on the barriers scale
were reverse coded since subscales were used to better understand both benefits and
barriers (Sechrist et al., 1987).
The standardized Cronbach’s alpha for the EBBS in a northern U.S. general adult
population was .95 with a test-retest reliability of .89 (Sechrist et al., 1987). The
Cronbach’s alpha for the 29-item benefit subscale was .954 and the 14-item barriers
subscale was .866 in the same population (Sechrist et al., 1987). Confirmatory factor
analysis revealed a two-factor solution that included a benefits and barriers factor
(Sechrist et al., 1987). Additionally, the EBBS has been used in a young adult cohort. In a
population of college students, a significant negative correlation was identified between
benefits and barriers (r = -.46, p<.05) (Brown, 2005). Reliability was confirmed in this
population of college students with a Cronbach’s alpha of .80 on the barriers subscale and
.92 on the benefits subscale (Brown, 2005). Although no studies were found in which the
EBBS was applied to individuals with NAFLD, the EBBS has been used in populations
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of chronic illness such as women with osteoarthritis (Shin et al., 2004) persons with HIV
(Rehm & Konkle-Parker, 2016), and individuals with multiple sclerosis (Stroud et al.,
2009).
Brief Illness Perception Questionnaire
The subjects’ perceptions of severity of illness related to NAFLD were measured
using the Brief Illness Perception Questionnaire (Brief IPQ) (Broadbent et al., 2006). The
Brief IPQ is a nine-item instrument established to concisely measure the cognitive and
emotional response related to a chronic illness (Broadbent et al., 2006). Five of the
instrument items were developed to assess the cognitive burden of illness, two items
measure emotional burden of illness, and one item assesses comprehension of illness
(Broadbent et al., 2006). Each item on the Brief IPQ is assessed on a scale from 0 to 10
where higher scores are indicative of a stronger perception of the dimension (Broadbent
et al., 2015). The instrument items assess perceived consequences, timeline, personal
control, treatment control, identity, concern, and coherence of illness and emotional
representation (Broadbent et al., 2015). While each dimension can be examined
separately, a total score can also be calculated by reverse scoring items 3, 4, and 7 and
adding these to items 1, 2, 5, 6, and 8. Total scores can range from 0 to 80 with a higher
total score reflecting a higher perceived threat of illness (Broadbent et al., 2015).
The initial psychometric data were tested in six groups of individuals with chronic
illness including myocardial infarction, renal disease, diabetes, and asthma (Broadbent
et al., 2006). Concurrent validity was demonstrated through comparing data from the
Brief IPQ and the previously established IPQ-revised in which 82% of items could be
categorized into the causal items from the IPQ-revised scale (Broadbent et al., 2006).
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Discriminant validity was examined to determine variation of illness perception based on
disease. As expected, those with more severe chronic illness such as myocardial
infarction had longer perceived illness timelines than those with reoccurring colds
(Broadbent et al., 2006). The Brief IPQ has been used in a variety of populations
including persons with cancer, metabolic disease, mental health disorders, neuromuscular
disorders, respiratory disease, and infectious disease (Broadbent et al., 2015). The Brief
IPQ has been used internationally in 36 countries and translated into 26 languages
(Broadbent et al., 2015).
Exercise Self-Efficacy Scale
Self-efficacy was measured in this study through the use of the Exercise SelfEfficacy Scale. The Exercise Self-Efficacy Scale (ESES) is a 10-item instrument that
measures three components of self-efficacy in subscales including task efficacy, coping
efficacy, and scheduling efficacy (Rodgers et al., 2002). Each item is scored on a 10point Likert scale ranging from “1” (not at all confident) to “10” (completely confident)
(Rodgers et al., 2002). A total score is calculated by summing the responses of each item
with a possible range of scores from 10 to 100 (Rodgers et al., 2002). A higher total
ESES score indicates a higher perceived exercise self-efficacy.
Initial validation data were collected in a random population of 203 adults
(Rodgers et al., 2002). Strong internal reliability was demonstrated through a Cronbach
alpha ranging from .72-.86 for each of the three subscales of the ESES. The reliability of
the ESES tool was also demonstrated in a general population of adults (n=56) with a
Cronbach alpha ranging from .77-.89 on the three subscales of the ESES (Rodgers et al.,
2002). Rodgers et al. (2008) performed a series of three studies to examine the exercise
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self-efficacy scale and included an exploratory factor analysis, confirmatory factor
analysis, and a 12-week intervention study. In the exploratory factor analysis with a
sample of 395 undergraduate college students, a direct oblimin technique was used and
three factors were extracted (task self-efficacy, scheduling self-efficacy, and coping selfefficacy) (Rogers et al., 2008). A confirmatory factor analysis in sample of 470
community-based participants yielded an acceptable model supporting the three-factor
model from the exploratory factor analysis (Rodgers et al., 2008). Lastly, a 12-week
exercise intervention study in an adult general population was conducted to discern
whether the ESES observed change in self-efficacy with an increase in activity level
(Rodgers et al., 2008). All three domains of the ESES demonstrated change over time
with the exercise intervention indicating that the ESES is an appropriate
multidimensional tool to assess exercise self-efficacy (Rodgers et al., 2008).
Concise Physical Activity Questionnaire
Level of physical activity was measured by the self-reported Concise Physical
Activity Questionnaire. The Concise Physical Activity Questionnaire (CPAQ) is a 4-item
instrument that measures the average self-reported participation in PA per week over the
past month (Sliter & Sliter, 2014). CPAQ items measured PA based on intensity and
include light aerobic, moderate aerobic, vigorous aerobic activity, and musclestrengthening activity (Sliter & Sliter, 2014). Response options are scored on a 5-point
Likert scale including options from “0” (Physically unable/not medically allowed to do
this or chose not to do this) to 4 (6-7 times per week) (Sliter & Sliter, 2014). A total score
is calculated by summing the unweighted responses to items 1, 2, and 4 and the weighted
response to item 3 (multiple the individual response x 2.5) (Sliter & Sliter, 2014). The
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possible scores on the CPAQ instrument range from 0 to 24 with a higher score indicative
of more time spent on average in PA per week within a one-month timeframe (Sliter &
Sliter, 2014). The CPAQ was developed to provide a short, simple, self-report measure of
PA that would be easy for researchers to score and simple for respondents to complete
(Sliter & Sliter, 2014). The brevity of the CPAQ instrument is considered a strength in
this study as the CPAQ is part of a larger battery of study instruments.
Initial testing of the validty of the CPAQ was collected in a population of college
students (Sliter & Sliter, 2014). During initial validation, CPAQ scores were found to be
inversely correlated with health problems (r = -.19, p < 0.01), BMI (r = -.32, p < 0.001),
and resting heart rate (r = -.28, p < 0.01) (Sliter & Sliter, 2014). Furthermore, CPAQ
scores were positively associated with verification of gym attendance (r =.52, p < 0.001)
(Sliter & Sliter, 2014). The CPAQ has also been utilized in a population of firefighters to
determine the potential impact of PA on burnout (Sliter & Sliter, 2014). Although the
CPAQ has not been used in persons with NAFLD, the preliminary findings from this tool
provide evidence for use of the CPAQ in other populations.
Demographic Intake Form
A structured questionnaire was developed by the investigator to obtain
demographic data from each study participant. The demographic intake form included
information regarding age, ethnicity, marital status, employment, disease specific
characteristics (i.e., duration of NAFLD, pre-cirrhosis vs cirrhosis), rating of current pain
perception (0-10 scale; no pain to worse pain possible), current prescription medications,
alcohol use history, and substance use.

33

Data Analysis
Data collected during this study were entered into IBM SPSS Statistics software
version 23.0 for data analysis and interpretation. All data were checked for completeness
and accuracy by the primary investigator. Frequency distributions were examined to
identify outliers or potential data entry errors. Statistical significance was determined by
using an alpha of p < 0.05. Descriptive statistics were used to describe the study
participants. The first research question listed below was analyzed using a multiple
regression model. The final research question was analyzed using the PROCESS macro
function described by Hayes (2009). This function assesses for mediation between the
independent and dependent variables.
1) Do symptoms of fatigue or depression, perceptions of level of illness severity or
benefits and barriers to physical activity predict the amount of self-reported
physical activity?
2) Does exercise self-efficacy mediate the relationship between perceptions of
benefits or barriers for physical activity and self-report physical activity?
Summary
This chapter provided an overview of the cross-sectional correlational study,
sample, data collection, procedures, human protection strategies, and data analysis. Data
collection occurred at the outpatient Piedmont Hepatology and Transplant Clinic in
Atlanta, GA. Exclusion and inclusion criteria were set prior to the study conduction and
all study procedures were approved by both Georgia State and Piedmont Healthcare
Institutional Review Boards. An informed consent and HIPAA agreement form were
explained in detail to each study participant and signed by the participant prior to data
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collection. A total of six study instruments and a demographic intake form were
collected. Data were then manually entered into SPSS for data analysis.

CHAPTER IV
STUDY RESULTS
The results from this cross-sectional, correlational study examining the
relationships of fatigue, depression, perceived illness severity, benefits and barriers to
physical activity on the self-reported level of physical activity are presented in this
chapter. A description of the study sample characteristics and findings are included.
Data were collected between October 2020 and May 2021 at a large hematology and
transplant clinic in Atlanta, GA. A total of 166 patients, reflected in Figure 2, were
approached regarding their interest in participating in the study and 34 declined to
participate. The remaining 132 patients were screened for eligibility and 19 were
excluded due to current use of antidepressant medication. Of the remaining study
participants, data from three participants were incomplete due to missing greater than
50% of the data points. These three participants were excluded from data analysis.
Participants that used either a cane or walker for mobility (n=12) were also excluded
from this study. After all exclusions, 98 study participants were included in the data
analysis with no missing data points.
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Figure 2. Study participant screening, eligibility, and inclusion
166 patients with NAFLD
approached

34 patients declined to participate

132 patients screened for
inclusion/exclusion criteria
19 patients excluded for current use of
antidepressant medication

Data Review

12 patients excluded due to use of
mobility devices (i.e. cane/walker)

3 participants were excluded due to
missing data
n=98

Description of Study Sample
Demographic information was collected from study participants and this
information is summarized in Table 1. The majority of study participants were over the
age of 50 with ages ranging from 23-75 and the mean age was 58.56 ± 9.1 years. Fortythree study participants were male and the remaining 55 were female. The vast majority
of study participants were White/Non-Hispanic (n=80), with 16 participants identifying
as Black/Non-Hispanic, and 2 participants identifying as Hispanic. A large majority of
participants completed either a high school diploma or a bachelor’s degree with only 13
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participants with higher levels of education. Variation in household income was noted
with a range of less than $20,000 to greater than $100,000 annually.
Table 1. Study Participant Demographics
Sample Characteristic
Sex

n=98
Male
Female

43
55

<39
30-39
40-49
50-59
60-70
>70

1
1
12
31
45
8

Age

Ethnicity
Black/Non-Hispanic
Hispanic/Latino
Non-Hispanic/White

16
2
80

High school diploma
Bachelor’s Degree
Master’s Degree
Doctorate Degree

35
50
8
5

Less than $20,000
$20,000-$39,000
$40,000-$59,000
$60,000-$79,000
$80,000-$99,000
Greater than $100,000

2
12
31
35
11
7

Education

Household Income

Table 2 demonstrates health demographics surveyed from all study participants
including body mass index (BMI), length of time since diagnosis, and current level of
pain. The average BMI of the participants was 32.98 ± 8.90 with a range of 14.64 to
61.88. The average duration of the diagnosis of NAFLD was for approximately two and
a half years (30 months), with this ranging from as little as six months to 20 years (241
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months). Pain was assessed on a numeric scale from 0-10, with the mean pain score of
0.998 ± 1.995.
Table 2. Health Demographics for Study Participants
BMI
Length of time since
diagnosis of NAFLD
(months)
Pain (0-10)

N
98
98

Minimum
14.64
6

Maximum
61.88
241

Mean
32.98
30.32

Std Deviation
8.90
36.69

98

0

10

0.998

1.995

Reliability of Study Instruments
The internal consistency of all study instruments were analyzed using Cronbach’s
coefficient alpha. The coefficient alphas of each instrument are reported in Table 3. The
exercise self-efficacy and exercise benefit/barrier scales were analyzed according to their
separate subscales. The coefficient alphas of the study instruments ranged from .645 to
.987 which is indicative of good internal reliability with the exception of the Concise
Physical Activity Scale (CPAQ). The Cronbach alpha for the CPAQ scale in this
population was .505 which is lower than desired. Initial testing of the CPAQ tool was
positive, however, this testing was done in a young, healthy population. The lower alpha
in this study population is attributed to the chronic nature of NAFLD, which may have
affected the reliability of this study instrument.

39

Table 3. Internal Consistency of Study Instruments
Study Instrument
PROMIS Fatigue Scale
PROMIS Depression Scale
Brief Illness Perception Questionnaire
Concise Physical Activity Scale
Exercise Self Efficacy Scale
Task Efficacy Subscale
Coping Subscale
Scheduling Subscale
Benefit Subscale
Barrier Subscale

Number
of Items
8
8
8
4

Cronbach Alpha

4
3
3
29
14

a = .706
a = .927
a = .970
a = .951
a = .823

a = .927
a = .987
a = .645
a = .505

Data Analysis Results
Descriptive Statistics for Major Study Variables
Six study instruments and a demographic intake form were used to collect data
regarding the variables of interest. Prior to data analysis, a thorough screen of all data for
data entry errors and missing data was performed. Additionally, a pre-analysis screen of
outliers, multicollinearity, homoscedasticity, normality, and linearity was performed.
Data normality was assessed by analyzing box plots and histograms and no outlying data
were found. All variables were normally distributed. Correlations were examined to
ensure adequate variance in the data set and to assess for multicollinearity between
independent variables. Multicollinearity was also assessed by examining the variance
inflation factor and a Durbin-Watson test was performed to assess for independent errors.
Table 4 demonstrates an overview of the descriptive statistics of each study instruments. .
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Table 4. Descriptive Statistics of Study Instruments
N

Minimum

Maximum

Mean

Std. Deviation

Depression
Fatigue
Total Barrier Subscale

98
98
98

8
8
14

32
40
42

11.47
19.25
33.98

4.73
10.18
4.27

Total Benefit Subscale

98

29

110

75.60

12.37

Total Exercise Self-Efficacy

98

10

100

52.48

22.19

Total Brief Illness Perception

98

4

71

33.68

12.91

Total Concise Physical
Activity

98

0

18

3.60

3.77

Depression
Depression was measured using the Patient-Reported Outcomes Measurement
Information System (PROMIS) depression short form 8a. Raw scores and total scores
were analyzed for the study population. The total scores for this study population ranged
from 8-32 with a mean depression total score of 11.47 ± 4.73. In addition to examining
raw total scores, data were converted to T-scores for review. Out of all study
participants, 77 had scores less than 55 and was considered normal, 18 had mild
depression, 3 with moderate depression, and none with severe depression. A total of 3
study participants scored above the cut-off score of 60 and were provided with referral
information to a psychiatric mental health practitioner for evaluation of depressive
symptoms.
Fatigue
Fatigue was measured using the Patient Reported Outcome Measurement
Information System (PROMIS) fatigue short form 8a. Raw scores and total scores were
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examined for the study population. The total fatigue scores for this population ranged
from 8-40 with a mean score of 19.25 ± 10.18. In addition to examining total scores, data
were converted into T-scores. Out of all study participants, 60 had PROMIS scores
indicating a normal response, 12 with mild fatigue, 20 with moderate fatigue, and 6 with
severe fatigue.
Exercise Self-Efficacy
Individualized self-exercise related to exercise was measures using the ExerciseSelf-Efficacy Scale. Items were summed to create a total score representing the overall
perceived exercise self-efficacy. The total scores of this instrument ranged from 10-100
with a mean score of 52.48 ± 22.19. On average, individuals with NAFLD reported a
moderate level of exercise self-efficacy. Study participants were most confident that they
could follow directions from an exercise instructor (mean = 6.44, ± 2.625, but least
confident that they could exercise when they don’t have time (mean=4.32 ± 2.452).
Exercise Benefits and Barriers
Perceived benefits and barriers to exercise were measured utilizing the Exercise
Benefits and Barriers scale. This study instrument is subdivided into two different
subscales, and data were further examined in benefits and barriers. A higher score on this
subscale represents a higher perceived level of barriers to participating in physical
activity. The total scores of the barrier scale ranged from 14 to 42 with a mean score of
33.98 ± 4.27. The highest scoring barrier to exercise was that “exercise tires me” (mean =
3.15 ± 0.664) and that “I am fatigued by exercise” (mean = 3.14 ± 0.642). The lowest
scoring barrier on this scale was that “my spouse does not encourage exercising” (mean =
2.0 3 ± 0.564). The total scores of the benefit scale ranged from 28 to 108 with a mean
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score of 75.60 ± 12.37. Participants felt most strongly that exercise would prevent
hypertension (mean = 3.05 ± 2.098) and heart attacks (mean = 2.93 ± 0.389).
Illness Perception
The individualized perception of illness was measured through the use of the
Brief Illness Perception Questionnaire (Brief IPQ). Study items were summed to
calculate total scores. Scores on this study instrument ranged from 4 to 71, with a mean
score of 33.68 ± 12.91. Respondents scored the highest on “how concerned are you
about your illness” (mean 6.48 ± 2.847) and “how long do you believe that your illness
will continue” (mean = 5.32 ± 2.798). However, respondents identified that they believe
that treatment does help their illness (mean 6.48 ± 2.19) and that their overall
understanding of NAFLD was high. The overall scoring of participants in this study
indicates that persons with NAFLD perceive a moderately high level of illness (mean =
33.68 ± 12.92).
Physical Activity
Physical activity was assessed using the Concise Physical Activity Questionnaire.
A total score was calculated by adding the unweighted responses to question 1, 2, and 4
and the weighted response to item 3. Total scores of this study instrument ranged from 0
to 18 with a mean score of 3.60 ± 3.773. These data suggests that the individuals with
NAFLD in this study are relatively inactive. The most common form of physical activity
was light aerobic activity (mean = 2.80 ± 2.328) and the least common form of physical
activity was vigorous aerobic activity with only one study participant participating in
aerobic activity. Only one study participant reported regularly participating in aerobic
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physical activity. Twenty-five study participants (25.5%) reported participating in no
regular physical activity.
Research Question One
1) Do symptoms of fatigue or depression, perceptions of level of illness severity or
benefits and barriers to physical activity predict the amount of self-reported
physical activity?
A simultaneous multiple linear regression model was used to answer research
question one using the Enter method in SPSS. Table 5 provides correlational data for
independent study variables as a check for multicollinearity. The variation inflation
factor (VIF) for each variable is presented in Table 6 and was also used to assess
multicollinearity. All VIF values for independent variables indicated no multicollinearity.
The Durbin-Watson statistics for this model was 2.052, thus, meeting the model
assumption for independent errors and no autocorrection.
Table 5. Descriptive & Correlational Data for all Major Study Variables (n=98)
Variable
1. Barriers
2. Benefits
3. Depression
4. Fatigue
5. Physical
Activity
6. Exercise SelfEfficacy
7. Perceived
illness severity

1
--.31**
-.11
-.11

2

3

4

5

6

--.27**
.45**

--.41**

---

.21**

.52**

.25**

-.31**

---

-.11

.41**

.40**

.55**

.50**

---

.02

.39**

.47**

.46**

-.29*

.42**

7

---
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Table 6. Multicollinearity Diagnostics
Variable

Variance Inflation Factor (VIF)

Barriers
Benefits
Depression
Fatigue
Perceived Illness Severity

1.146
1.471
1.385
1.506
1.572

The overall model summary is presented in Table 7.
Table 7. Linear Regression Model Summary

Model

R

R square

Adjusted R square

Std. Error of the Estimate

.667

.445

.415

2.90293

This multiple linear regression model included exercise benefits and barriers,
depression, fatigue, and illness perception as the independent variables of interest. A
multiple linear regression model was calculated to predict physical activity based on the
independent variables. A significant regression equation was found with the collective
module using exercise barriers, exercise benefits, depression, fatigue, perceived illness
severity, F (5,90) = 14.454, p < .000 with an R2 of .445 and adjusted R2 of .415. The
individual predictors were examined more in depth and the exercise benefit (p < .000)
and barrier scale (p < .000) were the only significant predictors of PA in this model.
Table 8 presents additional details on the coefficients and significance of model
variables.
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Table 8. Model Coefficients
Standardized
Coefficients Beta
-.426
.599
-.136
-.066

t

Sig

-.377
.184
-.108
-.024

Coefficient
Std. Error
.074
.029
.073
.036

-5.07
.480
-1.47
-.682

.000
.000
.145
.497

.014

.029

.047

.480

.250

B
Barriers
Benefits
Depression
Fatigue
Illness
Perception

Research Question Two
2) Does exercise self-efficacy mediate the relationship between perceptions of
benefits or barriers for physical activity and self-report physical activity?
To investigate this research question, a mediation analysis was performed using
PROCESS macro in SPSS. This PROCESS method described by Hayes (2009) was
chosen to test this complex model and to assess indirect effect through the proposed
mediator. Bootstrapping statistics were used to provide a resampling of datasets to
provide standard errors, confidence intervals, and to allow for hypothesis testing (Hayes,
2009). This analysis utilized a model number 4, confidence interval (CI) of 95%, and
5000 bootstraps.
The outcome variable for this analysis was physical activity. Two mediation models
were examined using the predictor variables of exercise benefits and exercise barriers and
the mediation variable was exercise self-efficacy. The indirect effect was tested using
non-parametric bootstrapping technique. In the first model summarized in Figure 3,the
indirect effect of exercise self-efficacy on exercise barriers and PA did not have a
statistically significant effect.
The indirect effect, summarized in Table 9, was negative (IE -.0460), but nonsignificant: 95% CI (-.1355, .0329) and reflects the indirect effect of self-efficacy on
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exercise barriers and physical activity. In this model, the lower limit CI was -.0135 and
the upper limit CI was .002. Since zero falls within the range of the CI in this model, the
null hypothesis was maintained.
Figure 3. Mediation Model for Exercise Barriers, Exercise Self-Efficacy, and Physical
Activity

b

6
-.5

,

.
p=

29

Exercise SelfEfficacy

b.

08
,p

=.

00

b -.14, p = .07

Exercise Barriers

PA

Table 9. Indirect Effect of Self-Efficacy on Exercise Barrier and Physical Activity

Self-Efficacy

Effect

BpptSE

BootLLCI

BootULCI

-.0460

.0424

-.1355

.0329

A second model shown in Figure 4 was analyzed to determine if there was an
indirect effect produced by exercise self-efficacy on exercise benefits and level of PA.
The indirect effect in this model was tested using a non-parametric bootstrapping method.
This model did produce a statistically significant model in which the indirect effect is
inferred to be non-zero. Table 10 demonstrates the indirect effect data which shows the
lower limit CI was .0172 and the upper limit CI was .0783. Thus, the indirect effect (IE =
.0436) was statistically significant (p .001): 95% CI = (.0172, .0783).
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Figure 4. Mediation Model for Exercise Benefits, Exercise Self-Efficacy, and Physical
Activity
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Table 10. Indirect Effect of Self-Efficacy on Exercise Benefit and Physical Activity

Self-Efficacy

Effect

BpptSE

BootLLCI

BootULCI

.0436

.0158

.0172

.0783

Summary
Six study instruments and a demographic intake forms were used to collect data
regarding dependent variables of interest in 98 individuals with nonalcoholic fatty liver
disease. Two research questions were developed to examine factors that influence
physical activity in persons with liver disease. Additionally, data were collected to
examine a potential mediation effect of exercise self-efficacy on overall physical activity.
Data were collected and analyzed through a simultaneous linear regression model. The
model was statistically significant and accounted for a total of 41.5% of the total variance
of the dependent variable. Perceived benefits and barriers to physical activity was found
to be statistically significant in this model for predicting physical activity. Additionally,
the mediation indirect effect was examined by using a bootstrap model. Exercise selfefficacy was not found to cause a significant mediation effect between exercise barriers
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and PA. However, a significant indirect mediating effect of exercise self-efficacy was
found between exercise benefits and PA.

CHAPTER V
RESULTS
The purpose of this to chapter is to present the interpretation of the findings
regarding the effects of perceptions of fatigue, depression, illness severity, exercise
benefits or barriers on the level of physical activity in individuals with NAFLD. This
chapter also provides an in-depth review of study findings in relation to existing literature
and the study framework, study strengths and limitations, implications for clinical
practice, and suggestions for future research. The data examined in this research study
adds to the body of research regarding individuals with non-alcoholic fatty liver disease
(NAFLD), their perceived symptom burden, and how factors associated with this illness
may impact their level of physical activity.
Discussion and Conclusions
While physical activity has been well-established as a main treatment component
of NAFLD (Chalassani et al., 2018) there remains a gap in understanding how to best
improve overall activity level in this population. Data from this study suggest that
persons with NAFLD are relatively inactive. Approximately 25% of this current
population reported participating in no physical activity. This finding is similar to
previous findings of PA in persons with NAFLD (Hallsworth et al., 2015; Krasnoff et al.,
2018). This is clinically significant because PA is a main treatment guideline for persons
with NAFLD and if not being followed accordingly there is concern for the worsening
continuum of NAFLD to cirrhosis (Chalassani et al., 2018). To our knowledge, this is
49
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the first study assessing depression, fatigue, illness perception, exercise benefits or
barriers and the relationship of these variables to physical activity in persons with
NAFLD. This study assessed the perceived illness burden, symptomatology, and level of
activity in an under-researched population and highlights the need for continued work in
this area.
Fatigue and Depression
In this study, the level of fatigue in persons with NAFLD was clinically significant.
Using the PROMIS fatigue scores, 38 participants had mild, moderate, or severe fatigue
which is approximately 38% of the study population (n=98). Data from this study further
supports current evidence (Assimakopoulos et al., 2018; Dwight et al., 2000; Newton
et al., 2008) that individuals with NAFLD have high levels of fatigue. Although fatigue
was not a significant predictor of PA in this study, previous data suggests that higher
levels of fatigue were correlated with reduced levels of PA in persons with NAFLD
(Mlynarsky et al., 2016).
In regards to additional symptomatology, there was variability in individual
reports of depression with approximately a fifth of participants scoring mild or higher on
the depression rating scale. Three study participants scored above the cutoff range for the
depression rating scale, which was indicative of severe depression. These three
participants were retained in the study since there had not received any previous
treatment. However, they were referred for additional screening and possible treatment of
depressive symptoms. A growing body of evidence suggest that depression and fatigue
commonly co-exist in individuals with chronic liver disease (Assimakopoulos et al.,
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2018; Dwight et al., 2000; Gerber et al., 2019) and the data from this study helps to
support this evidence.
Perceived Illness Severity
Perceived illness severity has been well documented as having a significant
impact on persons with chronic illness (Groarke et al., 2004) and is inversely related with
level of PA (Zoeckler et al., 2014). This study further supports this as a negative
correlation was found between perceived illness severity and level of PA (r = -.29,
p = .003). Despite respondents feeling as though treatment plans were helping their
illness, the overall scoring of participants in this study indicates that persons with
NAFLD perceive a moderately high level of illness.
Factors Predicting the Level of Physical Activity
Perceptions of depressive symptoms, fatigue, illness severity and benefits or
barriers were considered as potential factors influencing the current level of PA for
persons with NAFLD. The overall model demonstrated that 41.5% of the variance of the
level of PA was explained by the significant, independent variables. Standardized beta
coefficients were analyzed to better under the strength to which each independent
variable impacted the dependent variable.
Within the model itself, exercise benefits and exercise barriers were the only two
statistically significant variables predicting physical activity. This suggests that the
overall perception of benefit of exercise or barriers to exercise best predicted level of
activity. The perceived benefits of PA were a positive, moderate predictor of level of PA
while perceived barriers of PA were a negative, moderate predictor of PA.
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Exercise Self-Efficacy as a Potential Mediator of Benefits or Barriers to Physical
Activity
Self-efficacy has been well described as a major determinant of behavioral
activity change and is defined as the individual’s belief that they can successfully
implement the proposed behavior change (Bandura, 1977). Improved levels of selfefficacy have been correlated in prior studies to increased level of PA (Mo et al., 2011).
Exercise self-efficacy was examined as a potential mediator of the relationships between
perceived benefits or barriers and the current level of PA. Additionally, self-efficacy and
its impact on level of activity has also been studied in many groups of chronic illness
(Blake et al., 2016, Kasser & Komo, 2012; Zelber-Sagi et al., 2017). However, there
have been no studies specifically examining exercise self-efficacy in persons with
NAFLD.
Two mediation models were analyzed to determine if exercise self-efficacy
mediates the relationship between exercise benefits or barriers and PA. A bootstrapping
method was used to assess the role of self-efficacy as a mediator variable between
exercise benefits or barriers and level of PA. Bootstrapping generates a multitude of
samples through random repeated resampling through replacement (Hayes, 2009). In this
model, a bootstrapping of 5000 was completed to assess 5000 samples and to create
confidence intervals to answer the research question. Bootstrapping methods have had an
increased use in the past decade due to the use of additional analytical dashboards
through SPSS. The MACRO process method was used for this study due to its ability to
assess bootstrapping and the reduction of computational burden (Hayes, 2009). The use
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of bootstrapping methods also allows for more generalizability of study data due to the
resampling of data sets (Hayes, 2009). Although low levels of self-efficacy have been
described as a potential barrier to level of PA (Craike et al., 2013) the mediation model
analyzing the indirect effect of exercise self-efficacy on barriers was not statistically
significant. Thus, self-efficacy did not mediate the relationship between perceived
barriers and level of PA. However, the model examining exercise benefits and level of
PA was significant. This model suggests that the indirect effect of exercise self-efficacy
was significant on the effect of exercise benefits and level of PA. This may be attributed
to self-efficacy being viewed as a benefit of physical activity. As an example, an
increased level of exercise-self efficacy, may cause patients to have an increased
perception of the benefit of PA, thus, increasing level of activity.
Relationship to Theory
This study utilized the theoretical foundation of the Health Belief Model (HBM)
to examine relationships of study variables. The HBM is a widely used theory to
examine factors associated with behavioral changes (Rosenstock, 1974). The HBM has
also been widely used to study physical activity as a variable of interest (Hoseini et al.,
2014). In this study, the concept of perceived threat was measured by assessing the
perceived illness severity. Additionally, depression and fatigue were examined as
potential psychosocial risk factors in this theoretical model. The concept of benefit of
action was assessed by the exercise benefits scale and self-efficacy was also examined.
The underpinnings of this theory easily supported the analysis of study variables in
relationship to one another. Despite the theoretical framework, self-efficacy did not
mediate the relationship between exercise barriers and engagement in the health behavior.
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Also, fatigue and depression were not statistically significant in predicting level of
physical activity. Therefore, the research model was only partially supported by study
findings.
Limitations of Study
Several limitations of this study have been identified. First, this study utilized a
convenience sample population. Although the Piedmont clinic serves a large geographic
area, study participants were selected from this facility based on convenience for the
student PI. This should be evaluated to determine the possible effect of generalizing
study findings to a larger population. On average, it took study participants
approximately twenty minutes to complete all data collection. A limitation of this study
would be the respondent burden needed to collect all six study instruments. While
exercise benefits/barriers did prove to be a statistically significant finding in this study,
this questionnaire is lengthy and was skipped completely by three study participants
presumably due to its length. The reliability of the physical activity instrument used in
this study is lower than desired. The concise physical activity questionnaire (CPAQ) was
chosen due to its brevity and concern for respondent burden. Initial testing of the CPAQ
instrument seemed positive, however, the initial psychometric testing was performed in a
healthy population. The Cronbach alpha in this study population may be lower due to the
chronic nature of NAFLD which may change the reliability of this instrument. Another
limitation of this study was the self-reported nature of analyzing physical activity. In
similar studies, the use of biometric data or step technology have been used. Selfreported data was chosen for the use of this study due to funding restrictions. Due to the
higher acuity care provided by this Metro Atlanta clinic, patients may have a higher
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understanding of their disease process than patients in other more rural areas. The
potential impact of this should be considered when assessing for generalizability. Lastly,
all data collection occurred during the COVID-19 pandemic and researchers should
examine the possibility of this impacting study results due to gym closures, public health
concerns in crowded areas such as parks and recreational areas, and government orders
for quarantine. The COVID-19 pandemic may have impacted several study variables
including level of PA, depression, and fatigue.
Strengths of Study
The data collected in this research study has helped to extend the knowledge
regarding persons with NAFLD and factors that impact their participation in physical
activity. Additionally, information regarding symptom burden of those with NAFLD was
collected to better understand this population as a whole. This is the first known study to
examine the relationship between depression, fatigue, exercise benefits and barriers,
exercise self-efficacy, and perceived illness severity and level of physical activity. There
were limited missing data and the study instruments were found to have adequate internal
reliability. The study was conducted on the well-established theoretical foundation of the
Health-Belief Model (HBM). The HBM was used to assess relationships of study
variables. Lastly, a strength of this study was the ability to assess study variables in
varying degrees of liver illness. Variability of length of time since onset of illness was
identified with some participants having been affected for as little as six months and other
for over 20 years. Due to the progressive nature of NAFLD, the ability to assess length
of time since illness onset is a strength of this study. Lastly, the use of exercise self-
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efficacy as a mediator variable instead of a structural variable of the HBM provided an
innovate approach.
Implications of Findings on Clinical Practice
Physical activity is one of the main treatment strategies in managing NAFLD
(Chalassani et al., 2012). However, routine guidelines on intensity and duration of
activity are lacking and the overall level of activity of persons with NAFLD is low.
Clinical providers should continue to emphasize the importance of physical activity in
disease treatment and must consider an individualized approach to operationalizing
physical activity in this diverse population. Due to the percentage of persons with
NAFLD experiencing depression and fatigue (Gerber et al., 2019) routine
recommendations are needed on appropriate screening and treatment guidelines. NAFLD
has been described as the hepatic manifestation of metabolic disease and should be
considered by clinical providers when treating patients with other metabolic disorders.
Lastly, a better understanding of barriers to physical activity is needed to best guide
clinical practitioners on how to get their patients to better engage in regular activity.
Recommendations for Future Research
Due to the high prevalence of comorbid NAFLD and fatigue, recommendations of
future research are needed. Gerber et al. (2019) suggest the possible inclusion of
biomarker data in assessing fatigue in individuals with NAFLD. This could include
measuring pro-inflammatory cytokines or other objective physical performance markers
(Gerber et al., 2019). Findings from this research study provide additional details on gaps
in our current understanding of individuals with NAFLD, their symptom burden, and
their participation in physical activity. Since the overall data suggests that this study
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population was relatively inactive, a continued focus on variables associated with poor
levels of physical activity should be considered. Additional studies examining physical
activity using step technology or biometric data should be studied. Due to the current lack
of guidance on duration, intensity, and frequency of PA in this population of chronic
illness, future research should be considered to provide guidance. Since the perceived
benefit of exercise was the only significant predictor of physical activity, planning
interventional studies on improvement the overall perception of the benefit of activity
should be considered. Future studies may benefit from using a different measurement of
physical activity and should consider using biometric measurements for both fatigue and
physical activity. Exercise self-efficacy should be considered in future research to
promote level of PA in individuals with NAFLD. Additionally, the inclusion of NAFLD
in metabolic disease studies may be crucial to better understanding overall health in this
disease continuum.
Study Summary
This study sought to examine the effects of depression, fatigue, perceived illness,
exercise benefits or barriers on the level of physical activity in individuals with
nonalcoholic fatty liver disease (NAFLD) and if exercise self-efficacy mediated the
effects of benefits or barriers on current activity. Data collected from this study provided
additional evidence to support that persons with NAFLD are not participating in regular
physical activity. Data suggest that the overall perceived benefits or barriers of exercise
were the only study variables that significantly predicted physical activity, with a
stronger effect related to barriers. Exercise self-efficacy had a relatively small
mediational effect on the relationship between benefits and the current level of physical
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activity in persons with NAFLD. Greater emphasis is needed on assessing barriers for
physical activity and identifying strategies for promoting exercise self-efficacy in persons
with NAFLD.
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Appendix A
Nonalcoholic Fatty Liver Disease and Factors Influencing Physical Activity
Demographic Intake Form
1. Which of the following best describes your ethnicity/race? (Please check one)
o Asian/Pacific Islander
o African American/Black
o Hispanic/Latino
o Non-Hispanic/White
2. What is your highest level of education? (Please check one)
o Less than high school
o High School Diploma
o Bachelor’s Degree
o Master’s Degree
o Doctorate Degree
3. What is the estimated total annual income for your household? (Please select
one)
o Less than $20,000
o $20,000-$39,000
o $40,000-$59,000
o $60,000-$79,000
o $80,000-$99,000
o Greater than $100,000
4. What is your current level of pain on a scale from 0-10 (ten being the worst pain
you can imagine)?
____________________________________________________________
5. Do you use any equipment to help move around? (Examples: wheelchair, cane,
etc.)
Yes

No
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Appendix B

PROMIS Fatigue Form 8a can be obtained from
www.healthmeasures.net
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Emotional Distress – Depression – Short Form 8a
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Appendix C

PROMIS Depression Form 8a can be obtained from
www.healthmeasures.net
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Appendix D

The Exercise Benefits/Barriers Scale can be obtained from:
Sechrist, K. R., Walker, S. N., & Pender, N. J. (1987). Development and psychometric
evaluation of the exercise benefits/barriers scale. Research in Nursing & Health,
10(6), 357-365.

84

APPENDIX E
Concise Physical Activity Questionnaire CPAQ

85

Appendix E

doi: http://dx.doi.org/10.1037/t36189-000
Concise Physical Activity Questionnaire CPAQ
Items

Directions
Please think about the past month. During that time, approximately how many days per week
did you engage in each of the following types of physical activity for at least 20 consecutive
minutes?
Example 1. If you walk to work and it takes you 10 minutes each way, that would NOT count
because the minutes were not consecutive.
Example 2. If you walk to work and it takes you 20 minutes each way, then that would count as
performing light physical activity that day. You walked for at least 20 consecutive minutes that
day.

Items
1. Light aerobic activity (Ex: shopping, housework, leisurely walking)
2. Moderate aerobic activity (Ex: brisk walking, bicycling, tennis)
3. Vigorous aerobic activity (Ex: jogging/running, swimming laps, jumping rope)
4. Muscle-strengthening activity (Ex: lifting weights, pilates, yoga)
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Appendix F

doi: 10.1037/t10379-000

Brief Illness Perception Questionnaire
Items
For the following questions, please circle the number that best corresponds to your views:
How much does your illness affect your life?
0
1
2
3
4
no affect
at all

5

6

7

8

9

10
severely
affects my life

6

7

8

9

10
forever

7

8

9

10
extreme
amount of control

How much do you think your treatment can help your illness?
0
1
2
3
4
5
6
7
not at all

8

9

10
extremely
helpful

7

8

9

10
many severe
symptoms

6

7

8

9

10
extremely
concerned

6

7

8

9

10
understand
very clearly

How long do you think your illness will continue?
0
1
2
3
4
5
a very
short time

How much control do you feel you have over your illness?
0
1
2
3
4
5
6
absolutely
no control

How much do you experience symptoms from your illness?
0
1
2
3
4
5
6
no symptoms
at all
How concerned are you about your illness?
0
1
2
3
4
not at all
concerned

5

How well do you feel you understand your illness?
0
1
2
3
4
5
don't
understand
at all

PsycTESTS™ is a database of the American Psychological Association
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doi: 10.1037/t10379-000

Brief Illness Perception Questionnaire
Items
How much does your illness affect you emotionally? (e.g. does it make you angry, scared, upset or
depressed?)
0
1
2
3
4
5
6
7
8
9
10
not at all
extremely
affected
affected
emotionally
emotionally
Please list in rank-order the three most important factors that you believe caused your illness.
The most important causes for me:
1. __________________________________
2. __________________________________
3. __________________________________

PsycTESTS™ is a database of the American Psychological Association
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doi: 10.1037/t19246-000

Exercise Self-Efficacy Scale
Items
Task Efficacy
How confident are you that you can . . .
(1) pace yourself to avoid overexertion?
(2) perform all the required movements?
(3) follow directions from an instructor?
(4) check how hard your activity is making you work?

Coping
How confident are you that you can exercise when you are . . .
(1) tired?
(2) in a bad mood?
(3) feel you don’t have time?

Scheduling
How confident are you that you could . . .
(1) overcome obstacles that prevent you from participating regularly?
(2) make up times you missed?
(3) exercise regularly no matter what?
Note . Items were rated on 10-point Likert-type scales anchored with 1 = not at all confident and 10 =
completely confident .

PsycTESTS™ is a database of the American Psychological Association

